Status:

WITHDRAWN

Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care

Lead Sponsor:

Emory University

Collaborating Sponsors:

Novo Nordisk A/S

Conditions:

Diabetes

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

In the Emergency Department (ED), diabetes is commonly encountered as a secondary diagnosis and many patients with uncontrolled diabetes are admitted to the hospital after initial evaluation in the ED...

Eligibility Criteria

Inclusion

  • Subjects meeting all of the following criteria will be considered for enrollment into the study:
  • Males or females between the ages of 18 and 80 years admitted to a general medical service.
  • A known history of type 2 diabetes mellitus \> 3 months, receiving diet management, any combination of oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones) and/or insulin therapy.
  • Subjects must have an admission blood glucose \> 140 mg and \< 400 mg/dL and no evidence of ketoacidosis (serum bicarbonate \< 18 mEq/L, venous or arterial pH \< 7.30, positive serum or urinary ketones).

Exclusion

  • Subjects with increased blood glucose concentration, but without a known history of diabetes.
  • Subsequent finding of diabetic ketoacidosis or hyperosmolar non-ketotic syndrome after initial evaluation.
  • Patients with acute critical or surgical illness and/or expected to require admission to a critical care unit (ICU, CCU), or to undergo surgery during the hospitalization course.
  • History of current drug or alcohol abuse.
  • Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
  • Inability to give informed consent
  • Female patients who are pregnant or are breast feeding
  • Patients who have clinically significant liver disease with ALT/AST \> 3 X the upper range of normal
  • Patients with serum creatinine ≥3.5 mg/dL for males or ≥ 3.0 mg/dL for females or currently treated with dialysis

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00663624

Last Update

November 21 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.